Psychopharmacology and Aggression: II. A Meta-Analysis of Nonstimulant Medication Effects on Overt Aggression-Related Behaviors in Youth with SED

Journal of Emotional and Behavioral Disorders

Volumn 11, Issue 3, 2003, Pages 157-168

  Connor, Daniel F ^a   Thomas Boone, R ^b   Steingard, Ronald J ^a   Lopez, Ivan D ^a   Melloni, Richard H ^c  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b ST JOHN'S UNIVERSITY   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0141792419     PISSN: 10634266     EISSN: None     Source Type: Journal    
DOI: 10.1177/10634266030110030301     Document Type: Review

References (65)

1. Aman, M. G., Marks, R. E., Turbott, S. H., Wilsher, C. P., & Merry, S. N. (1991). Clinical effects of methylphenidate and thioridazine in intellectually subaverage children. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 246-256.
2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
3. Anderson, L. T., Campbell, M., Adams, P. B., Small, A. M., Perry, R., & Shell, J. (1989). The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children. Journal of Autism and Developmental Disorders, 19, 227-239.
4. Anderson, L. T., Campbell, M., Grega, D. M., Perry, R., Small, A. M., & Green, W. H. (1984). Haloperidol in the treatment of infantile autism: Effects on learning and behavioral symptoms. American Journal of Psychiatry, 141, 1195-1202.
5. Barrickman, L. L., Perry, P. J., Allen, A. J., Kuperman, S., Arndt, S. V., Hermann, K. J., et al. (1995). Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 649-657.
6. Biederman, J., Baldessarini, R. J., Wright, V., Knee, D., & Harmatz, J. S. (1989). A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 777-784.
7. Black, B., & Uhde, T. W. (1994). Treatment of elective mutism with fluoxetine: A double-blind, placebo-controlled study. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 1000-1006.
8. Borduin, C. M. (1999). Multisystemic treatment of criminality and violence in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 242-249.
9. Brestan, E. V., & Eyberg, S. M. (1998). Effective psychosocial treatments of conduct-disordered children and adolescents: Twentynine years, 82 studies, and 5,272 kids. Journal of Clinical Child Psychology, 27, 180-189.
10. Buitelaar, J. K., van der Gaag, R. J., Cohen-Kettenis, P., & Melman, C. T. M. (2001). A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. Journal of Clinical Psychiatry, 62(4), 239-248.
11. Campbell, M., Adams, P. B., Small, A. M., Kafantaris, V., Silva, R. R., Shell, J., et al. (1995). Lithium in hospitalized aggressive children with conduct disorder: A double-blind and placebo controlled study. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 445-453.
12. Campbell, M., Small, A. M., Green, W. H., Jennings, S. J., Perry, R., Bennett, W. G., et al. (1984). Behavioral efficacy of haloperidol and lithium carbonate. Archives of General Psychiatry, 41, 650-656.
13. Carlson, G. A., Rapport, M. D., Pataki, C. S., & Kelly, K. L. (1992). Lithium in hospitalized children at 4 and 8 weeks: Mood, behavior, and cognitive effects. Journal of Child Psychology and Psychiatry, 33, 411-425.
14. Casat, C. D., Pleasants, D. Z., & Van Wyck Fleet, J. (1987). A double-blind trial of bupropion in children with attention deficit disorder. Psychopharmacology Bulletin, 23(1), 120-122.
15. Clay, T. H., Gualtieri, C. T., Evans, R. W., & Gullion, C. M. (1988). Clinical and neuropsychological effects of the novel antidepressant bupropion. Psychopharmacology Bulletin, 24(1), 143-148.
16. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Erlbaum.
17. Conners, C. K., Casat, C. D., Gualtieri, C. T., Weller, E., Reader, M., Reiss, A., et al. (1996). Bupropion hydrochloride in attention deficit disorder with hyperactivity. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1314-1321.
18. Connor, D. F. (2002). Aggression and antisocial behavior in children and adolescents: Research and treatment. New York: Guilford Press.
19. Connor, D. F., Barkley, R. A., & Davis, H. T. (2000). A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clinical Pediatrics, 39(1), 15-25.
20. Connor, D. F., Glatt, S. J., Lopez, I. D., Jackson, D., & Melloni, R. H., Jr. (2002). Psychopharmacology and aggression: I. A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 253-261.
21. Connor, D. F., Melloni, R. H., Jr., & Harrison, R. J. (1998). Overt categorical aggression in referred children and adolescents. Journal of the American Academy of Child Adolescent Psychiatry, 37(1), 66-73.
22. Connor, D. F., Ozbayrak, K. R., Harrison, R. J., & Melloni, R. H., Jr. (1998). Prevalence and patterns of psychotropic and anticonvulsant medication use in children and adolescents referred to residential treatment. Journal of Child and Adolescent Psychopharmacology, 8(1), 27-38.
23. Connor, D. F., Ozbayrak, K. R., Kusiak, K. A., Caponi, A. B., & Melloni, R. H., Jr. (1997). Combined pharmacotherapy in children and adolescents in a residential treatment center. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 248-254.
24. Connor, D. F., & Steingard, R. J. (1996). A clinical approach to the pharmacotherapy of aggression in children and adolescents. Annals of the New York Academy of Sciences, 794, 290-307.
25. Cueva, J. E., Overall, J. E., Small, A. M., Armenteros, J. L., Perry, R., & Campbell, M. (1996). Carbamazepine in aggressive children with conduct disorder: A double-blind and placebo-controlled study. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 480-490.
26. Dodge, K. A., & Coie, J. D. (1987). Social-information processing factors in reactive and proactive aggression in children's peer groups. Journal of Personality and Social Psychology, 53, 1146-1158.
27. Donovan, S. J., Stewart, J. W., Nunes, E. V., Quitkin, F. M., Parides, M., Daniel, W., et al. (2000). Divalproex treatment for youth with explosive temper and mood lability: A double-blind, placebo-controlled cross-over design. American Journal of Psychiatry, 757, 818-820.
28. Durlak, J. A., Fuhrman, T., & Lampman, C. (1991), Effectiveness of cognitive-behavior therapy for maladapting children: A meta-analysis. Psychological Bulletin, 110, 204-214.
29. Emslie, G. J., Rush, A. J., Weinberg, W. A., Kowatch, R. A., Hughes, C. W., Carmody, T., et al. (1997). A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry, 54, 1031-1037.
30. Eveloff, H. H. (1966). Psychopharmacologic agents in child psychiatry. Archives of General Psychiatry, 14, 472-481.
31. Findling, R. L., McNamara, N. K., Branicky, L. A., Schluchter, M. D., Lemon, E., & Blumer, J. L. (2000). A double-blind pilot study of risperidone in the treatment of conduct disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 509-516.
32. Fish, B. (1969). Problems of diagnosis and the definition of comparable groups: A neglected issue in drug research with children. American Journal of Psychiatry, 125, 271-286.
33. Frick, P. J., Lahey, B. B., Loeber, R., Tannenbaum, L., Van Horn, Y., Christ, M. A. G., et al. (1993). Oppositional defiant disorder and conduct disorder: A meta-analytic review of factor analyses and cross-validation in a clinical sample. Clinical Psychology Review, 13, 319-340.
34. Goldberg, J. B., & Kurland, A. A. (1974, February-March). Pimozide in the treatment of behavioral disorders of hospitalized adolescents. The Journal of Clinical Pharmacology, 14, 134-138.
35. Greenhill, L. L., Solomon, M., Pleak, R., & Ambrosini, P. (1985). Molindone hydrochloride treatment of hospitalized children with conduct disorder. Journal of Clinical Psychiatry, 46(8), 20-25.
36. Henggeler, S. W., Clingempeel, W. G., Brondino, M. J., & Pickrel, S. G. (2002). Four-year follow-up of multisystemic therapy with substance-abusing and substance-dependent juvenile offenders. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 868-874.
37. Henggeler, S. W., Melton, G. B., & Smith, L. A. (1992). Family preservation using multisystemic therapy: An effective alternative to incarcerating serious juvenile offenders. Journal of Consulting and Clinical Psychology, 60, 953-961.
38. Hinshaw, S. P. (1987). On the distinction between attentional deficits/hyperactivity and conduct problems/aggression in child psychopathology. Psychological Bulletin, 101, 443-463.
39. Hunt, R. D., Minderaa, R. B., & Cohen, D. J. (1985). Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-cross-over therapeutic trial. Journal of the American Academy of Child and Adolescent Psychiatry, 24, 617-629.
40. Jaselskis, C. A., Cook, E. H., Fletcher, K. E., & Leventhal, B. L. (1992). Clonidine treatment of hyperactive and impulsive children with autistic disorder. Journal of Clinical Psychopharmacology, 12, 322-327.
41. Kazdin, A. E. (1980). Research design in clinical psychology. New York: Harper & Row.
42. Kazdin, A. E. (1995). Conduct disorders in childhood and adolescence. London: Sage.
43. Kumra, S., Frazier, J. A., Jacobsen, L. K., McKenna, K., Gordon, C. T., Lenane, M. C., et al. (1996). Childhood-onset schizophrenia: A double-blind clozapine-haloperidol comparison. Archives of General Psychiatry, 53, 1090-1091.
44. Leckman, J. F., Hardin, M. T., Riddle, M. A., Stevenson, J., Ort, S. I., & Cohen, D. J. (1991). Clonidine treatment of Gilles de la Tourette's syndrome. Archives of General Psychiatry, 48, 324-328.
45. Lipsey, M. W., & Wilson, D. B. (2001). Practical meta-analysis: Vol. 49. Applied social research methods series. Thousand Oaks, CA: Sage.
46. Loeber, R., & Schmaling, K. B. (1985). Empirical evidence for overt and covert patterns of antisocial conduct problems: A meta-analysis. Journal of Abnormal Child Psychology, 13, 337-352.
47. Malone, R. P., Delaney, M. A., Luebbert, J. F., Cater, J., & Campbell, M. (2000). A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder. Archives of General Psychiatry, 57, 649-654.
48. Mosteller, F. M., & Bush, R. R. (1954), Selected quantitative techniques. In G. Lindzey (Ed.), Handbook of social psychology: Vol. 1. Theory and method (pp. 289-334). Cambridge, MA: Addison-Wesley.
49. Mytton, J. A., DiGuiseppi, C., Gough, D. A., Taylor, R. S., & Logan, S. (2002). School-based violence prevention programs: Systematic review of secondary prevention trials. Archives of Pediatrics and Adolescent Medicine, 156, 752-762.
50. Naruse, H., Nagahata, M., Nakane, Y., Shirahashi, K., Takesada, M., & Yamazaki, K. (1982). A multi-center double-blind trial of pimozide (Orap), haloperidol and placebo in children with behavioral disorders, using cross-over design. Acta Paedopsychiatrica, 48(4), 173-184.
51. Perry, R., Campbell, M., Adams, P. B., Lynch, N., Spencer, E. K., Curren, E. L., et al. (1989). Long-term efficacy of haloperidol in autistic children: Continuous versus discontinuous drug administration. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 87-92.
52. Prince, J. B., Wilens, T. E., Biederman, J., Spencer, T. J., Millstein, R., Polisner, D. A., et al. (2000). A controlled study of nor-triptyline in children and adolescents with attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 10, 193-204.
53. Rifkin, A., Karajgi, B., Dicker, R., Perl, E., Boppana, V., Hasan, N., et al. (1997). Lithium treatment of conduct disorders in adolescents. American Journal of Psychiatry, 154, 554-555.
54. Rosenthal, R. (1991). Meta-analytic procedures for social research. Newbury Park, CA: Sage.
55. Scahill, L., Chappell, P. B., Kim, Y. S., Schultz, R. T., Katsovich, L., Shepherd, E., et al. (2001). A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. American Journal of Psychiatry, 158, 1067-1074.
56. Scott, S. (1998). Aggressive behaviour in childhood. British Medical Journal, 316, 202-206.
57. Sheard, M. H., Marini, J. L., Bridges, C. I., & Wagner, E. (1976). The effect of lithium on impulsive aggressive behavior in man. American Journal of Psychiatry, 133, 1409-1413.
58. Snedecor, G. W., & Cochran, W. G. (1989). Statistical methods. Ames: Iowa State University Press.
59. Spencer, T., Biederman, J., & Wilens, T. (2000). Pharmacotherapy of attention deficit hyperactivity disorder. Child and Adolescent Psychiatric Clinics of North America, 9(1), 77-97.
60. Tabachnic, B., & Fidell, L. (2001). Using multivariate statistics (4th ed.). Boston: Allyn & Bacon.
61. Van Bellinghen, M., & De Troch, C. (2001). Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: A double-blind, placebo-controlled pilot trial. Journal of Child and Adolescent Psychopharmacology, 11(1), 5-13.
62. Waizer, J., Polizos, P., Huffman, S. P., Engelhardt, D. M., & Margolis, R. A. (1972). A single-blind evaluation of thiothixene with outpatient schizophrenic children. Journal of Autism and Childhood Schizophrenia, 2, 378-386.
63. Werry, J. S. (1997). Severe conduct disorder -Some key issues. Canadian Journal of Psychiatry, 42, 577-583.
64. Willner, M. M., & Gordon, L. E. (1969). Psychotropic drugs in children. Clinical Pediatrics, 8, 193-200.
65. Wolf, F. M. (1986). Meta-analysis: Quantitative methods for research synthesis. Beverly Hills, CA: Sage.